BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11236214)

  • 1. Dermatopharmacology of a new combination gel formulation for the topical treatment of acne.
    Levy S
    Cutis; 2001 Feb; 67(2 Suppl):8-12. PubMed ID: 11236214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic studies with a new combination benzoyl peroxide/clindamycin topical gel in acne vulgaris.
    Ellis CN; Leyden J; Katz HI; Goldfarb MT; Hickman J; Jones TM; Tschen E
    Cutis; 2001 Feb; 67(2 Suppl):13-20. PubMed ID: 11236210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role for a new combination topical therapy in treating mild to moderate acne vulgaris.
    Tschen E
    Cutis; 2001 Feb; 67(2 Suppl):25-7. PubMed ID: 11236212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience results with clindamycin 1% benzoyl peroxide 5% gel (Duac) as monotherapy and in combination.
    Bikowski JB
    J Drugs Dermatol; 2005; 4(2):164-71. PubMed ID: 15776773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris.
    Tschen EH; Katz HI; Jones TM; Monroe EW; Kraus SJ; Connolly MA; Levy SF
    Cutis; 2001 Feb; 67(2):165-9. PubMed ID: 11236229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris.
    Dhawan SS
    Cutis; 2009 May; 83(5):265-72. PubMed ID: 19537284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel: a flexible component of acne management.
    Tanghetti E
    Cutis; 2009 Nov; 84(5 Suppl):18-24. PubMed ID: 19999189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [1 percent clindamycin phosphate solution versus 5 percent benzoyl peroxide gel in papulopustular acne].
    Schmidt JB; Neumann R; Fanta D; Raab W
    Z Hautkr; 1988 May; 63(5):374-6. PubMed ID: 2970159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product.
    Leyden JJ; Hickman JG; Jarratt MT; Stewart DM; Levy SF
    J Cutan Med Surg; 2001; 5(1):37-42. PubMed ID: 11281433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective, open-label, comparative study of clindamycin 1%/benzoyl peroxide 5% gel with adapalene 0.1% gel in Asian acne patients: efficacy and tolerability.
    Ko HC; Song M; Seo SH; Oh CK; Kwon KS; Kim MB
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):245-50. PubMed ID: 19438817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial.
    Kellett N; West F; Finlay AY
    Br J Dermatol; 2006 Mar; 154(3):524-32. PubMed ID: 16445786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new treatment for acne vulgaris combining benzoyl peroxide with clindamycin.
    Tschen E; Jones T
    J Drugs Dermatol; 2002 Sep; 1(2):153-7. PubMed ID: 12847739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of comedonal acne vulgaris with fixed-combination topical therapy.
    Gold MH; Baldwin H; Lin T
    J Cosmet Dermatol; 2018 Apr; 17(2):227-231. PubMed ID: 29380941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial.
    Tanghetti E; Abramovits W; Solomon B; Loven K; Shalita A
    J Drugs Dermatol; 2006 Mar; 5(3):256-61. PubMed ID: 16573259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development and optimization of a fixed combination of clindamycin and benzoyl peroxide aqueous gel.
    Bucks D; Sarpotdar P; Yu K; Angel A; Del Rosso J
    J Drugs Dermatol; 2009 Jul; 8(7):634-8. PubMed ID: 19588639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of a ceramide containing moisturizer followed by fixed-dose clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel in the morning in combination with a ceramide containing moisturizer followed by tretinoin 0.05% gel in the evening for the treatment of facial acne vulgaris.
    Zeichner JA; Patel RV; Haddican M; Wong V
    J Drugs Dermatol; 2012 Jun; 11(6):748-52. PubMed ID: 22648223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
    Draelos ZD; Potts A; AliĆ³ Saenz AB;
    Cutis; 2010 Dec; 86(6):310-8. PubMed ID: 21284283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination topical therapy in the treatment of acne.
    Del Rosso JQ
    Cutis; 2006 Aug; 78(2 Suppl 1):5-12. PubMed ID: 17966494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study.
    Bowman S; Gold M; Nasir A; Vamvakias G
    J Drugs Dermatol; 2005; 4(5):611-8. PubMed ID: 16167420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are 2 combined antimicrobial mechanisms better than 1 for the treatment of acne vulgaris? Clinical and antimicrobial results of a topical combination product containing 1% clindamycin and 5% benzoyl peroxide. Introduction.
    Leyden J
    Cutis; 2001 Feb; 67(2 Suppl):5-7. PubMed ID: 11236213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.